Filter News
Area of Research
News Topics
- (-) Biomedical (5)
- 3-D Printing/Advanced Manufacturing (15)
- Advanced Reactors (4)
- Artificial Intelligence (14)
- Big Data (3)
- Bioenergy (10)
- Biology (8)
- Biotechnology (3)
- Buildings (4)
- Chemical Sciences (12)
- Clean Water (1)
- Climate Change (12)
- Composites (4)
- Computer Science (17)
- Coronavirus (2)
- Critical Materials (1)
- Cybersecurity (7)
- Decarbonization (9)
- Education (3)
- Energy Storage (8)
- Environment (14)
- Exascale Computing (6)
- Frontier (7)
- Fusion (4)
- Grid (5)
- High-Performance Computing (16)
- Irradiation (1)
- Isotopes (5)
- Machine Learning (5)
- Materials (34)
- Materials Science (15)
- Microscopy (6)
- Molten Salt (1)
- Nanotechnology (4)
- National Security (4)
- Net Zero (2)
- Neutron Science (16)
- Nuclear Energy (11)
- Partnerships (19)
- Physics (6)
- Polymers (1)
- Quantum Computing (3)
- Quantum Science (9)
- Renewable Energy (1)
- Security (4)
- Simulation (9)
- Software (1)
- Summit (5)
- Sustainable Energy (8)
- Transportation (9)
Media Contacts
Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
Hilda Klasky, an R&D staff member in the Scalable Biomedical Modeling group at ORNL, has been selected as a senior member of the Association of Computing Machinery, or ACM.
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.